Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 3/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | SLC16A3 | O15427 | 7/20 | 0.56 |
| ▸ | SLC16A1 | P53985 | 7/20 | 0.56 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.55 |
| ▸ | TYR | P14679 | 1/20 | 0.55 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.55 |
| ▸ | MIF | P14174 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8649661 | 0.87 | CYP1A2 (0.78) | CYP1A2CYP3A4CYP2C9KDM4ELMNA | |
| SCHEMBL9360940 | 0.87 | CYP1A2 (0.78) | CYP1A2CYP3A4CYP2C9KDM4ELMNA | |
| SCHEMBL3020681 | 0.87 | CYP1A2 (0.58) | EGFRCYP1A2CYP3A4CYP2C9KDM4E | |
| SCHEMBL3020683 | 0.87 | CYP1A2 (0.58) | EGFRCYP1A2CYP3A4CYP2C9KDM4E | |
| SCHEMBL28820627 | 0.86 | CYP1A2 (0.56) | EGFRCYP1A2CYP3A4CYP2C9KDM4E | |
| SCHEMBL15428904 | 0.84 | KDM4E (0.68) | CYP1A2CYP3A4CYP2C9KDM4ELMNA | |
| SCHEMBL21457392 | 0.83 | EGFR (0.79) | EGFRCYP3A4KDM4ELMNAPKM | |
| SCHEMBL21457390 | 0.83 | EGFR (0.79) | EGFRCYP3A4KDM4ELMNAPKM | |
| SCHEMBL17831051 | 0.81 | KDM4E (0.68) | EGFRCYP1A2CYP3A4CYP2C9KDM4E | |
| SCHEMBL9358828 | 0.80 | TRIM24 (0.60) | CYP1A2CYP3A4KDM4ELMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802106-B2 | Cathode buffer layer material and organic or organic/inorganic hybrid photoelectric device comprising same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-10-31 | — | — | US | disclosed |
| US-20210198188-A1 | NOVEL CATHODE BUFFER LAYER MATERIAL AND ORGANIC OR ORGANIC/INORGANIC HYBRID PHOTOELECTRIC DEVICE COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2021-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802106-B2 | Cathode buffer layer material and organic or organic/inorganic hybrid photoelectric device comprising same | DCX, CDH1, CACNA2D3 | EGFR 4368/4885CYP1A2 4259/4885CYP3A4 3086/4885 |
| US-20210198188-A1 | NOVEL CATHODE BUFFER LAYER MATERIAL AND ORGANIC OR ORGANIC/INORGANIC HYBRID PHOTOELECTRIC DEVICE COMPRISING SAME | DCX, HCN3, CDH1 | EGFR 4330/4885CYP1A2 4481/4885CYP3A4 3511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.